Related Experiment Video
Updated: Jun 8, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Finding a contract research organization for your research trial.
Nicole Simunovic1, Sheila Sprague, Mohit Bhandari
1McMaster University, Department of Clinical Epidemiology and Biostatistics, Hamilton, Ontario L8L 8E3, Canada. simunon@mcmaster.ca
Journal of Long-Term Effects of Medical Implants
|October 14, 2010
Summary
Choosing the right clinical research organization (CRO) is crucial for successful clinical trials. This guide helps identify key attributes and uses for selecting the optimal CRO partner for your project.
Area of Science:
- Clinical trial management
- Pharmaceutical research
- Biotechnology services
Background:
- Clinical research organizations (CROs) offer vital support for clinical trial execution.
- The growing number of CROs presents challenges in selecting the most suitable partner.
- Effective CRO selection impacts project success from initiation to close-out.
Purpose of the Study:
- To outline essential attributes for evaluating and selecting a CRO.
- To present practical uses and considerations for CRO engagement.
- To provide examples of CROs across diverse therapeutic areas.
Main Methods:
- Review of CRO services and operational models.
- Analysis of key selection criteria for clinical trial outsourcing.
- Case examples of specialized CROs in different therapeutic fields.
Main Results:
- Identified critical factors for assessing CRO capabilities.
- Demonstrated the importance of aligning CRO specialization with project needs.
- Highlighted a range of CRO options for various clinical trial scales and complexities.
Conclusions:
- Strategic selection of a CRO is paramount for efficient clinical trial conduct.
- Understanding specific project requirements aids in identifying the best-fit CRO.
- This resource assists researchers in navigating CRO selection for optimal outcomes.
Related Concept Videos
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:56Ethics in Research
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...